Retracted: MyoD-dependent regulation of NF-κB activity couples cell-cycle withdrawal to myogenic differentiation

Skeletal Muscle

Volumn 2, Issue 1, 2012, Pages

  Parker, Maura H ^a,b,c   Von Maltzahn, Julia ^b   Bakkar, Nadine ^d   Al Joubori, Ban ^b   Ishibashi, Jeff ^b   Guttridge, Denis ^d   Rudnicki, Michael A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c Fred Hutchinson Cancer Research Center   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Differentiation; IKK; I B; Myoblasts; MyoD; Myogenesis; NF B; Skeletal muscle

Indexed keywords

EID: 84991734855     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-2-6     Document Type: Article

References (39)

1. Hayden MS, Ghosh S: Shared principles in NF-kappaB signalling. Cell 2008, 132:344-362.
2. Baldwin AS Jr: The NF-kappaB and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
3. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000, 18:621-663.
4. Skaug B, Jiang X, Chen ZJ: The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 2009, 78:769-796.
5. Parker MH, Seale P, Rudnicki MA: Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 2003, 4:497-507.
6. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75:1351-1359.
7. Braun T, Rudnicki MA, Arnold HH, Jaenisch R: Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 1992, 71:369-382.
8. Asakura A, Komaki M, Rudnicki M: Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.
9. Sabourin LA, Girgis-Gabardo A, Seale P, Asakura A, Rudnicki MA: Reduced differentiation potential of primary MyoD-/-myogenic cells derived from adult skeletal muscle. J Cell Biol 1999, 144:631-643.
10. Yablonka-Reuveni Z, Rudnicki MA, Rivera AJ, Primig M, Anderson JE, Natanson P: The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev Biol 1999, 210:440-455.
11. Cornelison DD, Olwin BB, Rudnicki MA, Wold BJ: MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev Biol 2000, 224:122-137.
12. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999, 19:5785-5799.
13. Bakkar N, Guttridge DC: NF-kappaB signalling: a tale of two pathways in skeletal myogenesis. Physiol Rev 2010, 90:495-511.
14. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr: NF-kappaBinduced loss of MyoD messenger RNA: possible role in muscle decay and cachexia [see comments]. Science 2000, 289:2363-2366.
15. Didonato JA: Assaying for I kappa B kinase activity. Methods Enzymol 2000, 322:393-400.
16. Ishibashi J, Perry RL, Asakura A, Rudnicki MA: MyoD induces myogenic differentiation through cooperation of its NH2-and COOH-terminal regions. J Cell Biol 2005, 171:471-482.
17. Ladner KJ, Caligiuri MA, Guttridge DC: Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 2003, 278:2294-2303.
18. Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, Carathers M, Acharyya S, Rudnicki MA, Hollenbach AD, Guttridge DC: IKK/NF-kappaB regulates skeletal myogenesis via a signalling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 2008, 180:787-802.
19. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC: Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999, 98:859-869.
20. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA: Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996, 12:1173-1180.
21. Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, Sicinski P: Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 1999, 97:767-777.
22. Rao SS, Kohtz DS: Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J Biol Chem 1995, 270:4093-4100.
23. Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase [see comments]. Science 1995, 267:1022-1024.
24. Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB: Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol 1996, 16:7043-7053.
25. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995, 267:1018-1021.
26. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells [see comments]. Science 1995, 267:1024-1027.
27. Figliola R, Maione R: MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors. J Cell Physiol 2004, 200:468-475.
28. Zhang P, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ: p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev 1999, 13:213-224.
29. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82:675-684.
30. Frost RA, Lang CH: Skeletal muscle cytokines: regulation by pathogenassociated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care 2005, 8:255-263.
31. James PL, Jones SB, Busby WH Jr, Clemmons DR, Rotwein P: A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J Biol Chem 1993, 268:22305-22312.
32. Ewton DZ, Coolican SA, Mohan S, Chernausek SD, Florini JR: Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J Cell Physiol 1998, 177:47-57.
33. Ewton DZ, Florini JR: IGF binding proteins-4,-5 and-6 may play specialized roles during L6 myoblast proliferation and differentiation. J Endocrinol 1995, 144:539-553.
34. Rotwein P, James PL, Kou K: Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol Endocrinol 1995, 9:913-923.
35. Florini JR, Ewton DZ, Magri KA, Mangiacapra FJ: IGFs and muscle differentiation. Adv Exp Med Biol 1993, 343:319-326.
36. Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E: Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signalling during skeletal muscle differentiation. Matrix Biol 2006, 25:332-341.
37. Hayashi Y, Liu CY, Jester JJ, Hayashi M, Wang IJ, Funderburgh JL, Saika S, Roughley PJ, Kao CW, Kao WW: Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signalling. Dev Biol 2005, 277:222-234.
38. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA: MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996, 10:1173-1183.
39. Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, Carathers M, Li Z-W, Beg A, Ghosh S, Sahenk Z, et al: IKK/NF-kB signalling interplay in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007, 117:889-901.